Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-5,240
Closed -$495K 467
2023
Q3
$495K Hold
5,240
0.01% 320
2023
Q2
$526K Buy
5,240
+256
+5% +$23.8K 0.01% 310
2023
Q1
$404K Buy
4,984
+102
+2% +$8.17K 0.01% 346
2022
Q4
$365K Sell
4,882
-62
-1% -$4.82K 0.01% 344
2022
Q3
$409K Sell
4,944
-280
-5% -$24.6K 0.02% 306
2022
Q2
$418K Sell
5,224
-220
-4% -$22.3K 0.02% 310
2022
Q1
$616K Buy
5,444
+280
+5% +$31.4K 0.02% 266
2021
Q4
$588K Buy
5,164
+186
+4% +$20K 0.02% 266
2021
Q3
$579K Buy
4,978
+699
+16% +$87.5K 0.02% 246
2021
Q2
$515K Hold
4,279
0.02% 263
2021
Q1
$461K Buy
+4,279
New +$475K 0.02% 271

Other funds holding DVA

Glenview Trust's DVA Position: Q4 2023 in Review

Glenview Trust sold out of DaVita (DVA) in Q4 2023, closing a stake of 5,240 shares — an estimated $495K sold.

Glenview Trust first reported a position in DVA in Q1 2021 and held it in 11 quarters. The position peaked at $616K in Q1 2022. 536 funds tracked by Wall St. Rank hold DVA as of Q4 2023.

  • Glenview Trust reported no remaining DaVita position as of Q4 2023 after selling out during the quarter.
  • Glenview Trust sold 5,240 DaVita shares in Q4 2023, an estimated $495K.
  • Glenview Trust first reported a position in DaVita in Q1 2021 and held it in 11 quarters.
  • Glenview Trust's DaVita position peaked at $616K in Q1 2022.
  • 536 funds tracked by Wall St. Rank held DaVita as of Q4 2023.

Based on Glenview Trust's 13F filing for Q4 2023, filed 12 Feb 2024.